Search
Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.
A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.
Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.
Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.
New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.